ANDA 60096, held by Pfizer. Tetracycline Hydrochloride.
As of Nov 16, 2026, ANDA 60096 (Tetracyn), held by Pfizer, was not approved, with 0 approved supplements and 0 published complete response letters.
| Tetracyn250MG/VIAL · injectable;injection | Tetracycline Hydrochloride | Discontinued |
| Tetracyn500MG/VIAL · injectable;injection | Tetracycline Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters